CEVIMELINE HYDROCHLORIDE

CEVIMELINE HYDROCHLORIDE was reported 2790 times

CEVIMELINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIAC VALVE ABSCESS 2 0.0215
1 SJOGREN'S SYNDROME 10 0.0170
2 PARAKERATOSIS 4 0.0123
3 VASCULAR ACCESS SITE COMPLICATION 3 0.0119
4 PERIORBITAL PAIN 7 0.0083
5 CHEST WALL MASS 2 0.0077
6 CHONDROMALACIA 2 0.0070
7 ACQUIRED OESOPHAGEAL WEB 2 0.0059
8 CONJUNCTIVITIS BACTERIAL 2 0.0058
9 ASTHMA EXERCISE INDUCED 2 0.0057
10 EYELID PAIN 11 0.0054
11 BURNING MOUTH SYNDROME 3 0.0053
12 LIFE EXPECTANCY SHORTENED 3 0.0053
13 ACCELERATED HYPERTENSION 2 0.0053
14 ALTERED VISUAL DEPTH PERCEPTION 4 0.0049
15 INFUSION SITE DISCOMFORT 5 0.0048
16 CARDITIS 2 0.0048
17 CORONA VIRUS INFECTION 2 0.0047
18 UTERINE PROLAPSE 5 0.0046
19 SIALOADENITIS 6 0.0044
20 URETHRAL STENOSIS 3 0.0044
21 PROTHROMBIN TIME ABNORMAL 3 0.0043
22 LEFT ATRIAL DILATATION 5 0.0039
23 EXTRADURAL ABSCESS 3 0.0038
24 VASCULAR ACCESS COMPLICATION 3 0.0037
25 VERTEBRAL FORAMINAL STENOSIS 3 0.0036
26 PAROTITIS 4 0.0034
27 PRIMARY SEQUESTRUM 3 0.0033
28 POST-ACUTE COVID-19 SYNDROME 4 0.0032
29 OSTEOSCLEROSIS 5 0.0032
30 CORNEAL ABRASION 4 0.0029
31 ARACHNOIDITIS 2 0.0029
32 ENTEROCOCCAL BACTERAEMIA 3 0.0028
33 DENTAL RESTORATION FAILURE 2 0.0028
34 OESOPHAGEAL SPASM 5 0.0027
35 CHLAMYDIAL INFECTION 2 0.0026
36 BRONCHITIS BACTERIAL 2 0.0026
37 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
38 PERIPHERAL EMBOLISM 3 0.0026
39 PRE-EXISTING CONDITION IMPROVED 16 0.0026
40 INFUSION SITE PRURITUS 8 0.0025
41 INTERMITTENT CLAUDICATION 4 0.0025
42 CYSTITIS INTERSTITIAL 4 0.0025
43 RECTAL PROLAPSE 3 0.0025
44 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
45 DEVICE INFUSION ISSUE 6 0.0024
46 CARDIAC STRESS TEST ABNORMAL 2 0.0024
47 RECTAL TENESMUS 3 0.0024
48 APTYALISM 2 0.0023
49 ADENOMA BENIGN 2 0.0023
50 INFUSION SITE BRUISING 5 0.0023
51 CATHETER SITE PRURITUS 2 0.0023
52 ANOGENITAL WARTS 2 0.0022
53 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 5 0.0022
54 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
55 TONGUE DRY 3 0.0022
56 RHONCHI 3 0.0022
57 ACTINOMYCOSIS 2 0.0021
58 NOROVIRUS INFECTION 3 0.0021
59 SEBORRHOEIC KERATOSIS 3 0.0021
60 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
61 VOCAL CORD DISORDER 4 0.0020
62 NEURITIS 3 0.0019
63 BONE MARROW OEDEMA 2 0.0019
64 ANTIPHOSPHOLIPID SYNDROME 3 0.0019
65 BINGE EATING 2 0.0019
66 PLEURITIC PAIN 5 0.0018
67 DRY AGE-RELATED MACULAR DEGENERATION 2 0.0018
68 COMPLEX PARTIAL SEIZURES 2 0.0018
69 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 3 0.0018
70 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
71 ENTERITIS INFECTIOUS 3 0.0018
72 INFUSION SITE SWELLING 11 0.0017
73 ADMINISTRATION SITE PAIN 2 0.0017
74 OPHTHALMIC HERPES ZOSTER 3 0.0017
75 PULSE ABNORMAL 4 0.0017
76 THROAT CANCER 7 0.0017
77 BLADDER SPASM 3 0.0016
78 INTERVERTEBRAL DISCITIS 3 0.0016
79 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
80 JOINT CREPITATION 3 0.0015
81 NEPHROGENIC ANAEMIA 7 0.0015
82 ACROCHORDON 2 0.0015
83 SKIN INJURY 5 0.0015
84 SHOULDER ARTHROPLASTY 4 0.0015
85 CHRONIC FATIGUE SYNDROME 2 0.0014
86 RIGHT VENTRICULAR FAILURE 10 0.0014
87 INFUSION SITE ERYTHEMA 12 0.0014
88 ATYPICAL MYCOBACTERIAL INFECTION 2 0.0014
89 GLOSSITIS 5 0.0014
90 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 2 0.0014
91 HYPERTONIC BLADDER 4 0.0014
92 BILIARY DILATATION 2 0.0014
93 OESOPHAGEAL DISORDER 5 0.0013
94 ORAL SURGERY 3 0.0013
95 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
96 BACTERIAL VAGINOSIS 2 0.0013
97 MULTIPLE ALLERGIES 10 0.0013
98 BREAST CANCER RECURRENT 4 0.0013
99 SINUS OPERATION 3 0.0013
100 FOREIGN BODY SENSATION IN EYES 8 0.0013
101 SPINAL OSTEOARTHRITIS 11 0.0013
102 RADIUS FRACTURE 3 0.0012
103 TRIGEMINAL NEURALGIA 5 0.0012
104 FACET JOINT SYNDROME 4 0.0012
105 EYE PAIN 69 0.0012
106 CARTILAGE INJURY 3 0.0012
107 EXOSTOSIS 11 0.0012
108 ARTHROPOD STING 2 0.0012
109 URINARY TRACT INFECTION BACTERIAL 3 0.0012
110 TONGUE ULCERATION 4 0.0012
111 HAEMORRHAGE URINARY TRACT 3 0.0012
112 INFUSION SITE PAIN 15 0.0012
113 OCULAR DISCOMFORT 13 0.0012
114 ACTINIC KERATOSIS 3 0.0012
115 DRY MOUTH 92 0.0011
116 SEASONAL ALLERGY 16 0.0011
117 AORTIC VALVE STENOSIS 2 0.0011
118 GINGIVITIS 6 0.0011
119 FACIAL BONES FRACTURE 4 0.0011
120 LARGE INTESTINAL ULCER 3 0.0011
121 SCLERODERMA 4 0.0011
122 INJECTION SITE PAPULE 5 0.0011
123 HYPERKERATOSIS 6 0.0011
124 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
125 AURA 2 0.0011
126 CHRONIC SINUSITIS 4 0.0011
127 DYSPNOEA AT REST 3 0.0010
128 HAEMOTHORAX 3 0.0010
129 EARLY SATIETY 2 0.0010
130 COELIAC DISEASE 10 0.0010
131 FOOT OPERATION 5 0.0010
132 CANDIDA INFECTION 17 0.0010
133 EMPYEMA 2 0.0010
134 LIP DRY 9 0.0010
135 ENURESIS 4 0.0010
136 GALLBLADDER OPERATION 4 0.0010
137 SPINAL FUSION SURGERY 4 0.0010
138 TRIGGER FINGER 4 0.0010
139 MENISCUS INJURY 6 0.0010
140 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
141 IMPAIRED GASTRIC EMPTYING 13 0.0010
142 FOREIGN BODY IN THROAT 3 0.0010
143 DILATATION VENTRICULAR 2 0.0010
144 TONGUE DISCOMFORT 4 0.0009
145 ANAEMIA MACROCYTIC 2 0.0009
146 HEREDITARY ANGIOEDEMA 10 0.0009
147 AUTOIMMUNE DISORDER 9 0.0009
148 DRY EYE 46 0.0009
149 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
150 INFUSION SITE HAEMORRHAGE 3 0.0009
151 ONYCHOMYCOSIS 4 0.0009
152 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
153 PEPTIC ULCER 3 0.0009
154 DENTAL CARIES 10 0.0009
155 FOOT FRACTURE 17 0.0009
156 SLEEP APNOEA SYNDROME 17 0.0009
157 CHRONIC GASTRITIS 2 0.0009
158 EYE DISCHARGE 9 0.0009
159 BREAKTHROUGH PAIN 2 0.0009
160 AORTIC STENOSIS 3 0.0009
161 ROTATOR CUFF SYNDROME 11 0.0009
162 HANGOVER 3 0.0009
163 EYE IRRITATION 49 0.0009
164 NECROTISING FASCIITIS 3 0.0009
165 SQUAMOUS CELL CARCINOMA 8 0.0008
166 SYSTEMIC LUPUS ERYTHEMATOSUS 30 0.0008
167 HYPERLIPIDAEMIA 10 0.0008
168 LIMB OPERATION 4 0.0008
169 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
170 SPONDYLITIS 3 0.0008
171 SCIATICA 13 0.0008
172 FOOT DEFORMITY 9 0.0008
173 INFUSION SITE EXTRAVASATION 5 0.0008
174 CATHETER SITE HAEMORRHAGE 2 0.0008
175 PHOTOPHOBIA 15 0.0008
176 CORONARY ARTERY STENOSIS 4 0.0008
177 SNORING 3 0.0008
178 CLAVICLE FRACTURE 3 0.0008
179 GINGIVAL DISORDER 3 0.0008
180 AORTIC ARTERIOSCLEROSIS 2 0.0008
181 DRUG TITRATION ERROR 2 0.0008
182 CATHETER SITE PAIN 2 0.0008
183 RHINOVIRUS INFECTION 3 0.0008
184 SOMNAMBULISM 5 0.0008
185 RESPIRATORY TRACT CONGESTION 12 0.0008
186 OSTEOARTHRITIS 32 0.0008
187 OESOPHAGEAL CANDIDIASIS 3 0.0008
188 ANGIONEUROTIC OEDEMA 2 0.0007
189 BLOOD POTASSIUM ABNORMAL 2 0.0007
190 CANDIDIASIS 3 0.0007
191 LOCALISED INFECTION 18 0.0007
192 BURSITIS 9 0.0007
193 FIBROMYALGIA 18 0.0007
194 EAR CONGESTION 2 0.0007
195 CLUMSINESS 2 0.0007
196 CARDIOMEGALY 9 0.0007
197 ASTHENOPIA 4 0.0007
198 SPINAL STENOSIS 3 0.0007
199 TOOTH FRACTURE 8 0.0007
200 OSTEOPENIA 11 0.0007
201 DROOLING 5 0.0007
202 LYMPHOEDEMA 5 0.0007
203 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
204 BONE DISORDER 13 0.0007
205 KNEE OPERATION 7 0.0007
206 EYE INFECTION 8 0.0007
207 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
208 HAND FRACTURE 5 0.0007
209 POOR PERIPHERAL CIRCULATION 3 0.0007
210 DIVERTICULUM 5 0.0007
211 SHOULDER OPERATION 3 0.0007
212 SALIVARY HYPERSECRETION 7 0.0007
213 ABNORMAL SENSATION IN EYE 3 0.0007
214 BACTERIAL INFECTION 13 0.0007
215 GRAFT VERSUS HOST DISEASE 5 0.0007
216 LACRIMATION INCREASED 21 0.0007
217 HIATUS HERNIA 9 0.0007
218 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
219 DRY THROAT 7 0.0007
220 TOOTH ABSCESS 7 0.0007
221 INTERVERTEBRAL DISC PROTRUSION 15 0.0007
222 ORAL CANDIDIASIS 9 0.0007
223 TOOTH INFECTION 9 0.0007
224 LIGAMENT RUPTURE 3 0.0007
225 SINUS HEADACHE 4 0.0007
226 FEELING DRUNK 5 0.0007
227 CYSTITIS 21 0.0007
228 NEURALGIA 16 0.0007
229 LUMBAR VERTEBRAL FRACTURE 3 0.0007
230 INSURANCE ISSUE 10 0.0007
231 DYSAESTHESIA 2 0.0007
232 CHEST X-RAY ABNORMAL 2 0.0007
233 EYE OPERATION 3 0.0007
234 NERVE COMPRESSION 6 0.0006
235 SYNOVIAL CYST 3 0.0006
236 LARYNGEAL OEDEMA 4 0.0006
237 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
238 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
239 ORAL DISCOMFORT 9 0.0006
240 SCOLIOSIS 4 0.0006
241 OLIGURIA 4 0.0006
242 SKIN LACERATION 7 0.0006
243 DEFORMITY 6 0.0006
244 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
245 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
246 SKIN ABRASION 3 0.0006
247 PRODUCT USE COMPLAINT 10 0.0006
248 SPUTUM DISCOLOURED 6 0.0006
249 VIRAL UPPER RESPIRATORY TRACT INFECTION 3 0.0006
250 NERVE INJURY 7 0.0006
251 SINUSITIS 64 0.0006
252 RASH VESICULAR 3 0.0006
253 GASTROENTERITIS 9 0.0006
254 CHOLECYSTECTOMY 7 0.0006
255 PRODUCT PREPARATION ISSUE 4 0.0006
256 PANCREATIC DISORDER 3 0.0006
257 HOSPICE CARE 6 0.0006
258 ANKYLOSING SPONDYLITIS 8 0.0006
259 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
260 FLUID INTAKE REDUCED 3 0.0006
261 MENINGITIS 4 0.0006
262 COLITIS ISCHAEMIC 4 0.0006
263 CORONARY ARTERIAL STENT INSERTION 3 0.0006
264 TOE AMPUTATION 3 0.0006
265 DRUG DELIVERY SYSTEM MALFUNCTION 3 0.0006
266 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
267 PERIPHERAL VASCULAR DISORDER 3 0.0006
268 RESPIRATION ABNORMAL 4 0.0006
269 JOINT EFFUSION 4 0.0006
270 LARGE INTESTINE POLYP 4 0.0006
271 PULMONARY HYPERTENSION 12 0.0006
272 MALABSORPTION 3 0.0006
273 NO THERAPEUTIC RESPONSE 7 0.0006
274 MOUTH ULCERATION 12 0.0006
275 SMALL INTESTINAL OBSTRUCTION 7 0.0006
276 ULCER 9 0.0006
277 PHARYNGOLARYNGEAL PAIN 3 0.0006
278 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
279 STRESS FRACTURE 3 0.0006
280 CHEILITIS 3 0.0006
281 PHARYNGITIS STREPTOCOCCAL 6 0.0006
282 OROPHARYNGEAL DISCOMFORT 5 0.0006
283 OSTEOMYELITIS 10 0.0006
284 END STAGE RENAL DISEASE 10 0.0005
285 ASPIRATION 6 0.0005
286 JAW DISORDER 3 0.0005
287 MAJOR DEPRESSION 4 0.0005
288 NONSPECIFIC REACTION 3 0.0005
289 PSORIATIC ARTHROPATHY 22 0.0005
290 TOOTH DISORDER 12 0.0005
291 HERPES ZOSTER 31 0.0005
292 STREPTOCOCCAL INFECTION 3 0.0005
293 NECROSIS 3 0.0005
294 MIDDLE INSOMNIA 10 0.0005
295 HYPOAESTHESIA ORAL 8 0.0005
296 PERIORBITAL SWELLING 3 0.0005
297 CHOLECYSTITIS ACUTE 3 0.0005
298 AUTOIMMUNE THYROIDITIS 2 0.0005
299 GENERALISED ERYTHEMA 3 0.0005
300 DERMATITIS CONTACT 6 0.0005
301 EAR INFECTION 14 0.0005
302 SCAR 9 0.0005
303 MUSCULOSKELETAL DISCOMFORT 9 0.0005
304 KNEE ARTHROPLASTY 11 0.0005
305 CORONARY ARTERY BYPASS 3 0.0005
306 ENTEROCOLITIS 3 0.0005
307 RALES 3 0.0005
308 APHTHOUS ULCER 4 0.0005
309 BRONCHITIS 38 0.0005
310 GASTROINTESTINAL INFLAMMATION 4 0.0005
311 DECREASED INTEREST 3 0.0005
312 LIGAMENT SPRAIN 5 0.0005
313 PLEURISY 3 0.0005
314 RENAL CYST 4 0.0005
315 GINGIVAL PAIN 4 0.0005
316 APHONIA 7 0.0005
317 CARPAL TUNNEL SYNDROME 7 0.0005
318 GASTROOESOPHAGEAL REFLUX DISEASE 40 0.0005
319 SENSORY LOSS 4 0.0005
320 EMPHYSEMA 5 0.0005
321 SINUS TACHYCARDIA 7 0.0005
322 TASTE DISORDER 10 0.0005
323 PARALYSIS 7 0.0005
324 ARTHRITIS BACTERIAL 2 0.0005
325 TENDON RUPTURE 6 0.0005
326 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
327 STAPHYLOCOCCAL INFECTION 16 0.0005
328 FUNGAL INFECTION 16 0.0005
329 TENDERNESS 5 0.0005
330 WEIGHT FLUCTUATION 5 0.0005
331 TRANSFUSION 5 0.0005
332 MUSCULOSKELETAL DISORDER 9 0.0005
333 AORTIC VALVE INCOMPETENCE 2 0.0005
334 BODY HEIGHT DECREASED 5 0.0005
335 GLAUCOMA 9 0.0005
336 PSEUDOMONAS INFECTION 4 0.0005
337 BLOOD POTASSIUM DECREASED 14 0.0005
338 CARDIAC OPERATION 4 0.0005
339 INCOHERENT 3 0.0005
340 ORAL HERPES 9 0.0005
341 CHAPPED LIPS 2 0.0005
342 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
343 PRODUCT DOSE OMISSION IN ERROR 13 0.0005
344 PAIN IN JAW 13 0.0005
345 KIDNEY INFECTION 9 0.0005
346 POLYP 3 0.0005
347 HIP ARTHROPLASTY 7 0.0005
348 PULMONARY CONGESTION 6 0.0005
349 WALKING AID USER 3 0.0005
350 INJECTION SITE NODULE 5 0.0005
351 LYMPHOMA 7 0.0005
352 ABDOMINAL ABSCESS 2 0.0005
353 TENDONITIS 7 0.0005
354 UPPER LIMB FRACTURE 9 0.0005
355 URINARY TRACT INFECTION 77 0.0005
356 CATHETERISATION CARDIAC 2 0.0005
357 BASAL CELL CARCINOMA 7 0.0004
358 MYOSITIS 4 0.0004
359 DYSPHONIA 26 0.0004
360 SINUS CONGESTION 6 0.0004
361 PLEURAL EFFUSION 27 0.0004
362 GASTROENTERITIS VIRAL 8 0.0004
363 LIMB INJURY 12 0.0004
364 MITRAL VALVE INCOMPETENCE 5 0.0004
365 ABNORMAL LOSS OF WEIGHT 3 0.0004
366 JOINT SWELLING 53 0.0004
367 SCAB 5 0.0004
368 EAR DISORDER 2 0.0004
369 HAIR GROWTH ABNORMAL 3 0.0004
370 CONJUNCTIVITIS 8 0.0004
371 ARTHRITIS INFECTIVE 2 0.0004
372 HYPOPHAGIA 11 0.0004
373 MASS 6 0.0004
374 STOMATITIS 26 0.0004
375 NEPHROPATHY 4 0.0004
376 ARTERIOSCLEROSIS 4 0.0004
377 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
378 COVID-19 PNEUMONIA 5 0.0004
379 UNEVALUABLE EVENT 32 0.0004
380 RHEUMATOID ARTHRITIS 48 0.0004
381 CARDIAC TAMPONADE 2 0.0004
382 IRRITABLE BOWEL SYNDROME 9 0.0004
383 EYE INFLAMMATION 4 0.0004
384 GASTRITIS 11 0.0004
385 WRIST FRACTURE 5 0.0004
386 POST PROCEDURAL COMPLICATION 8 0.0004
387 PARAESTHESIA ORAL 6 0.0004
388 FLUID OVERLOAD 6 0.0004
389 VITAMIN D DEFICIENCY 4 0.0004
390 ORAL DISORDER 3 0.0004
391 MELAENA 9 0.0004
392 PHARYNGEAL SWELLING 4 0.0004
393 SPINAL OPERATION 5 0.0004
394 CEREBRAL DISORDER 3 0.0004
395 HIP FRACTURE 13 0.0004
396 ACTIVITIES OF DAILY LIVING IMPAIRED 8 0.0004
397 SINUS DISORDER 8 0.0004
398 OVARIAN CYST 4 0.0004
399 PRODUCT AVAILABILITY ISSUE 9 0.0004
400 MUSCLE ATROPHY 5 0.0004
401 FEEDING DISORDER 8 0.0004
402 FLUID RETENTION 20 0.0004
403 NEPHROLITHIASIS 18 0.0004
404 SURGERY 23 0.0004
405 PERICARDIAL EFFUSION 9 0.0004
406 CACHEXIA 2 0.0004
407 FOOD ALLERGY 3 0.0004
408 ANKLE FRACTURE 6 0.0004
409 TOOTHACHE 7 0.0004
410 POOR VENOUS ACCESS 4 0.0004
411 PELVIC FRACTURE 3 0.0004
412 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
413 JOINT STIFFNESS 10 0.0004
414 DRUG SCREEN POSITIVE 3 0.0004
415 OCULAR HYPERAEMIA 18 0.0004
416 THROAT IRRITATION 17 0.0004
417 INCONTINENCE 4 0.0004
418 JOINT DISLOCATION 4 0.0004
419 BLOOD ALBUMIN DECREASED 3 0.0004
420 TRICUSPID VALVE INCOMPETENCE 3 0.0004
421 MIGRAINE 36 0.0004
422 CELLULITIS 19 0.0004
423 ATRIAL FLUTTER 3 0.0004
424 NASAL CONGESTION 22 0.0004
425 COMPRESSION FRACTURE 2 0.0004
426 DYSPNOEA EXERTIONAL 14 0.0004
427 POOR QUALITY SLEEP 8 0.0004
428 MYASTHENIA GRAVIS 3 0.0004
429 BRUXISM 2 0.0004
430 FRACTURE 7 0.0004
431 BLOOD URINE PRESENT 7 0.0004
432 BACK INJURY 4 0.0004
433 OESOPHAGITIS 4 0.0004
434 ESCHERICHIA INFECTION 3 0.0004
435 APHASIA 11 0.0004
436 PERIPHERAL COLDNESS 5 0.0004
437 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
438 CHOKING SENSATION 2 0.0004
439 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
440 LIVER DISORDER 16 0.0004
441 MENTAL STATUS CHANGES 10 0.0004
442 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
443 ILLNESS 37 0.0004
444 HAEMORRHOIDS 7 0.0004
445 INJECTION SITE RASH 11 0.0004
446 GLOSSODYNIA 8 0.0004
447 SNEEZING 8 0.0004
448 SKIN INFECTION 4 0.0004
449 OROPHARYNGEAL PAIN 33 0.0004
450 THERAPY NON-RESPONDER 16 0.0004
451 OXYGEN SATURATION DECREASED 20 0.0004
452 TARDIVE DYSKINESIA 10 0.0004
453 IMPAIRED DRIVING ABILITY 4 0.0004
454 EYE SWELLING 13 0.0003
455 SUBDURAL HAEMATOMA 5 0.0003
456 SKIN ULCER 9 0.0003
457 IMPAIRED QUALITY OF LIFE 5 0.0003
458 MUSCLE STRAIN 3 0.0003
459 BLOOD PRESSURE DECREASED 23 0.0003
460 RESPIRATORY TRACT INFECTION 9 0.0003
461 ORTHOSTATIC HYPOTENSION 6 0.0003
462 LOCAL SWELLING 6 0.0003
463 ARTHROPATHY 19 0.0003
464 GROIN PAIN 3 0.0003
465 GRIP STRENGTH DECREASED 3 0.0003
466 LUNG INFILTRATION 3 0.0003
467 FACIAL PAIN 3 0.0003
468 PULMONARY OEDEMA 15 0.0003
469 HAEMOLYTIC ANAEMIA 3 0.0003
470 GASTROINTESTINAL INFECTION 3 0.0003
471 DERMATITIS 7 0.0003
472 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
473 LEUKOCYTOSIS 6 0.0003
474 VIRAL INFECTION 11 0.0003
475 RESTLESS LEGS SYNDROME 6 0.0003
476 ADRENAL INSUFFICIENCY 4 0.0003
477 NOCTURIA 4 0.0003
478 PRESYNCOPE 8 0.0003
479 DEVICE FAILURE 5 0.0003
480 BURNING SENSATION 23 0.0003
481 FALL 109 0.0003
482 INJECTION SITE URTICARIA 8 0.0003
483 INCREASED TENDENCY TO BRUISE 3 0.0003
484 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
485 HYPERHIDROSIS 42 0.0003
486 UROSEPSIS 3 0.0003
487 FEELING COLD 9 0.0003
488 LIMB DISCOMFORT 10 0.0003
489 PERSONALITY CHANGE 3 0.0003
490 PHARYNGITIS 4 0.0003
491 DEHYDRATION 43 0.0003
492 LUNG INFECTION 5 0.0003
493 SWOLLEN TONGUE 10 0.0003
494 CATARACT 19 0.0003
495 LACERATION 3 0.0003
496 BLOOD SODIUM DECREASED 6 0.0003
497 SPINAL DISORDER 3 0.0003
498 HEAD INJURY 10 0.0003
499 RED BLOOD CELL COUNT DECREASED 9 0.0003
500 INJECTION SITE IRRITATION 4 0.0003
501 HYPERSOMNIA 9 0.0003
502 PULMONARY FIBROSIS 6 0.0003
503 LOWER LIMB FRACTURE 6 0.0003
504 ACUTE RESPIRATORY FAILURE 6 0.0003
505 ATELECTASIS 3 0.0003
506 ERUCTATION 6 0.0003
507 INFLAMMATION 16 0.0003
508 HEART RATE IRREGULAR 7 0.0003
509 RHINORRHOEA 20 0.0003
510 CARDIAC FLUTTER 2 0.0003
511 DIZZINESS POSTURAL 3 0.0003
512 WEIGHT DECREASED 86 0.0003
513 DIPLOPIA 8 0.0003
514 ANGINA UNSTABLE 2 0.0003
515 CHOKING 6 0.0003
516 BRADYPHRENIA 2 0.0003
517 THERAPY CHANGE 3 0.0003
518 HAND DEFORMITY 4 0.0003
519 DYSGRAPHIA 2 0.0003
520 CHRONIC KIDNEY DISEASE 23 0.0003
521 GASTROINTESTINAL DISORDER 27 0.0003
522 RESPIRATORY DISORDER 9 0.0003
523 INJECTION SITE BRUISING 24 0.0003
524 HYPOTONIA 3 0.0003
525 BLOOD CHOLESTEROL INCREASED 14 0.0003
526 URINARY RETENTION 10 0.0003
527 COUGH 84 0.0003
528 SEPTIC SHOCK 13 0.0003
529 ARTHRALGIA 124 0.0003
530 PAIN OF SKIN 8 0.0003
531 PRODUCT ADMINISTRATION ERROR 6 0.0003
532 PRODUCT DOSE OMISSION ISSUE 87 0.0003
533 EPISTAXIS 22 0.0003
534 HEADACHE 184 0.0003
535 BLOOD TESTOSTERONE DECREASED 2 0.0003
536 THERAPY CESSATION 15 0.0003
537 OSTEOPOROSIS 12 0.0003
538 GASTRIC DISORDER 10 0.0003
539 CONTUSION 28 0.0003
540 VENTRICULAR EXTRASYSTOLES 3 0.0003
541 INFLUENZA 32 0.0003
542 NECK PAIN 16 0.0003
543 MUSCULOSKELETAL STIFFNESS 25 0.0003
544 APPLICATION SITE REACTION 2 0.0003
545 PNEUMONIA 92 0.0003
546 INJECTION SITE PRURITUS 19 0.0003
547 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
548 SKIN DISCOLOURATION 13 0.0003
549 DRUG ERUPTION 5 0.0003
550 FLATULENCE 16 0.0003
551 EATING DISORDER 6 0.0003
552 PNEUMONIA ASPIRATION 7 0.0003
553 ARTHRITIS 22 0.0003
554 DRUG EFFECT DECREASED 15 0.0003
555 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
556 OEDEMA 15 0.0003
557 INFECTION 40 0.0003
558 DERMATITIS BULLOUS 2 0.0003
559 BIPOLAR DISORDER 3 0.0003
560 PULMONARY THROMBOSIS 3 0.0003
561 PAIN IN EXTREMITY 81 0.0003
562 NEEDLE ISSUE 8 0.0003
563 ARRHYTHMIA 13 0.0003
564 DYSPHAGIA 26 0.0003
565 BLOOD GLUCOSE FLUCTUATION 3 0.0003
566 PALPITATIONS 32 0.0003
567 GASTROINTESTINAL PAIN 3 0.0003
568 PRODUCTIVE COUGH 13 0.0003
569 NASOPHARYNGITIS 50 0.0003
570 UNRESPONSIVE TO STIMULI 7 0.0003
571 BACK PAIN 63 0.0003
572 EXPIRED PRODUCT ADMINISTERED 9 0.0003
573 DYSKINESIA 11 0.0003
574 CONSTIPATION 59 0.0003
575 LIP SWELLING 9 0.0003
576 SKIN HAEMORRHAGE 4 0.0003
577 CONDITION AGGRAVATED 82 0.0003
578 GAIT INABILITY 9 0.0003
579 DYSGEUSIA 20 0.0003
580 SLEEP DISORDER 19 0.0003
581 PULMONARY MASS 4 0.0003
582 THINKING ABNORMAL 5 0.0003
583 IMMUNODEFICIENCY 4 0.0003
584 ORAL PAIN 6 0.0003
585 COVID-19 47 0.0003
586 RASH PAPULAR 6 0.0003
587 SPEECH DISORDER 14 0.0003
588 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
589 DYSARTHRIA 10 0.0003
590 FLUSHING 27 0.0003
591 INTESTINAL OBSTRUCTION 10 0.0003
592 HEPATIC ENZYME INCREASED 18 0.0003
593 ECONOMIC PROBLEM 4 0.0003
594 POLLAKIURIA 11 0.0003
595 MICTURITION URGENCY 3 0.0003
596 DIARRHOEA 169 0.0003
597 AMNESIA 17 0.0003
598 WEIGHT INCREASED 58 0.0003
599 ATRIOVENTRICULAR BLOCK 2 0.0003
600 MUSCULOSKELETAL CHEST PAIN 4 0.0003
601 CONCUSSION 2 0.0003
602 DYSPNOEA 146 0.0003
603 VASCULITIS 3 0.0003
604 DELUSION 4 0.0003
605 ABDOMINAL PAIN UPPER 53 0.0003
606 EAR PAIN 5 0.0003
607 CHILLS 30 0.0003
608 SEXUAL DYSFUNCTION 3 0.0003
609 BRAIN FOG 4 0.0003
610 ATAXIA 3 0.0003
611 HAEMATOCRIT DECREASED 5 0.0003
612 ACCIDENT 3 0.0003
613 SEPSIS 28 0.0003
614 WOUND 7 0.0003
615 BLOOD PRESSURE INCREASED 38 0.0002
616 NIGHT SWEATS 8 0.0002
617 MUSCULOSKELETAL PAIN 13 0.0002
618 INTERSTITIAL LUNG DISEASE 12 0.0002
619 FEELING ABNORMAL 59 0.0002
620 OEDEMA PERIPHERAL 30 0.0002
621 LUNG DISORDER 12 0.0002
622 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
623 MULTIPLE FRACTURES 4 0.0002
624 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
625 INJECTION SITE EXTRAVASATION 3 0.0002
626 INJECTION SITE WARMTH 5 0.0002
627 INFLUENZA LIKE ILLNESS 20 0.0002
628 OSTEONECROSIS OF JAW 6 0.0002
629 GENERALISED OEDEMA 3 0.0002
630 CYST 3 0.0002
631 HAIR COLOUR CHANGES 3 0.0002
632 TOOTH EXTRACTION 3 0.0002
633 GAIT DISTURBANCE 46 0.0002
634 PERIPHERAL SWELLING 37 0.0002
635 BONE PAIN 14 0.0002
636 BLOOD UREA INCREASED 4 0.0002
637 PERICARDITIS 4 0.0002
638 RETCHING 5 0.0002
639 PARANOIA 4 0.0002
640 BLOOD MAGNESIUM DECREASED 2 0.0002
641 NEUROPATHY PERIPHERAL 22 0.0002
642 PRURITUS GENERALISED 5 0.0002
643 CARDIAC MURMUR 2 0.0002
644 THERAPEUTIC RESPONSE DECREASED 14 0.0002
645 SWELLING FACE 15 0.0002
646 NODULE 3 0.0002
647 MENTAL DISORDER 10 0.0002
648 DISCOMFORT 14 0.0002
649 DEAFNESS 6 0.0002
650 BLOOD CALCIUM INCREASED 2 0.0002
651 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
652 MALAISE 100 0.0002
653 HYPOXIA 8 0.0002
654 HYPOAESTHESIA 34 0.0002
655 LYMPHADENOPATHY 8 0.0002
656 ATRIAL FIBRILLATION 22 0.0002
657 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
658 INJECTION SITE ERYTHEMA 28 0.0002
659 MEMORY IMPAIRMENT 31 0.0002
660 GALLBLADDER DISORDER 4 0.0002
661 MALIGNANT MELANOMA 3 0.0002
662 DYSPEPSIA 22 0.0002
663 QUALITY OF LIFE DECREASED 3 0.0002
664 PARAESTHESIA 35 0.0002
665 ANAL INCONTINENCE 2 0.0002
666 SYNOVITIS 4 0.0002
667 INSOMNIA 59 0.0002
668 CHEST PAIN 41 0.0002
669 CRYING 8 0.0002
670 WHEEZING 13 0.0002
671 ACCIDENTAL OVERDOSE 8 0.0002
672 INJECTION SITE REACTION 15 0.0002
673 DYSURIA 8 0.0002
674 MUSCLE TWITCHING 5 0.0002
675 HYPOKALAEMIA 10 0.0002
676 DIVERTICULITIS 6 0.0002
677 PAIN 133 0.0002
678 NAUSEA 171 0.0002
679 HUNGER 3 0.0002
680 ANAEMIA 41 0.0002
681 HYPOTENSION 43 0.0002
682 SWELLING 20 0.0002
683 BLOOD TEST ABNORMAL 3 0.0002
684 DEVICE OCCLUSION 3 0.0002
685 EYE DISORDER 7 0.0002
686 FEELING HOT 13 0.0002
687 CARDIAC FAILURE CONGESTIVE 17 0.0002
688 THERAPY INTERRUPTED 15 0.0002
689 SYNCOPE 21 0.0002
690 ERYTHEMA 43 0.0002
691 EYE PRURITUS 7 0.0002
692 BALANCE DISORDER 18 0.0002
693 FATIGUE 162 0.0002
694 HYPERTENSION 44 0.0002
695 ANOSMIA 3 0.0002
696 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
697 HYPERTHYROIDISM 3 0.0002
698 HERNIA 4 0.0002
699 INTENTIONAL PRODUCT MISUSE 18 0.0002
700 PYREXIA 71 0.0002
701 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
702 CHEST DISCOMFORT 21 0.0002
703 TREMOR 34 0.0002
704 ASCITES 6 0.0002
705 VISION BLURRED 28 0.0002
706 ASTHMA 23 0.0002
707 TACHYCARDIA 18 0.0002
708 MUSCULAR WEAKNESS 23 0.0002
709 BLOOD PRESSURE ABNORMAL 4 0.0002
710 VOMITING 94 0.0002
711 RASH 87 0.0002
712 HEART RATE DECREASED 7 0.0002
713 INJURY 14 0.0002
714 PSORIASIS 26 0.0002
715 DEPRESSION 45 0.0002
716 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
717 INFUSION RELATED REACTION 13 0.0002
718 RENAL FAILURE 26 0.0002
719 PHARYNGEAL OEDEMA 3 0.0002
720 EAR DISCOMFORT 2 0.0002
721 PRODUCT PREPARATION ERROR 4 0.0002
722 DIZZINESS 97 0.0002
723 RIB FRACTURE 4 0.0002
724 SOMNOLENCE 39 0.0002
725 ABDOMINAL PAIN 45 0.0002
726 ANXIETY 55 0.0002
727 HAEMATOMA 5 0.0002
728 TOOTH LOSS 4 0.0002
729 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
730 RESPIRATORY FAILURE 14 0.0002
731 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
732 PRODUCT SUBSTITUTION ISSUE 11 0.0002
733 MUSCLE SPASMS 35 0.0002
734 PNEUMOTHORAX 3 0.0002
735 HYPOTHYROIDISM 6 0.0002
736 PLATELET COUNT DECREASED 20 0.0002
737 BREAST PAIN 2 0.0002
738 JOINT INJURY 4 0.0002
739 IMPAIRED WORK ABILITY 4 0.0002
740 LIVER FUNCTION TEST INCREASED 4 0.0002
741 INJECTION SITE PAIN 57 0.0002
742 SKIN CANCER 4 0.0002
743 HALLUCINATION 14 0.0002
744 DECREASED ACTIVITY 2 0.0002
745 MUSCLE TIGHTNESS 3 0.0002
746 ABDOMINAL DISCOMFORT 31 0.0002
747 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
748 BACK DISORDER 3 0.0002
749 IMPAIRED HEALING 6 0.0002
750 OSTEONECROSIS 6 0.0002
751 HEART RATE INCREASED 18 0.0002
752 ABNORMAL DREAMS 5 0.0002
753 PROCEDURAL PAIN 5 0.0002
754 STEVENS-JOHNSON SYNDROME 4 0.0002
755 TYPE 2 DIABETES MELLITUS 6 0.0002
756 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
757 HEMIPARESIS 3 0.0002
758 PRURITUS 68 0.0002
759 APPLICATION SITE PRURITUS 4 0.0002
760 DRUG DOSE OMISSION 29 0.0002
761 ANGINA PECTORIS 5 0.0002
762 TINNITUS 8 0.0002
763 DEVICE DEFECTIVE 3 0.0002
764 ABDOMINAL DISTENSION 18 0.0002
765 ELECTROLYTE IMBALANCE 2 0.0002
766 LIVER FUNCTION TEST ABNORMAL 5 0.0002
767 BLINDNESS 7 0.0002
768 METASTASES TO LIVER 3 0.0002
769 COLD SWEAT 3 0.0002
770 HEAD DISCOMFORT 3 0.0002
771 BLOOD CREATININE INCREASED 11 0.0002
772 PRODUCT ADHESION ISSUE 6 0.0002
773 THIRST 3 0.0002
774 ASTHENIA 63 0.0002
775 ROAD TRAFFIC ACCIDENT 7 0.0002
776 GOUT 3 0.0002
777 WITHDRAWAL SYNDROME 7 0.0002
778 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
779 DRUG INEFFECTIVE 218 0.0002
780 PELVIC PAIN 3 0.0002
781 PRODUCT USE ISSUE 31 0.0002
782 DRY SKIN 22 0.0002
783 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
784 CYTOPENIA 2 0.0002
785 ANAPHYLACTIC REACTION 9 0.0002
786 VISUAL IMPAIRMENT 20 0.0002
787 HEPATIC STEATOSIS 3 0.0002
788 HEPATIC FUNCTION ABNORMAL 6 0.0002
789 NERVOUS SYSTEM DISORDER 5 0.0002
790 HOT FLUSH 12 0.0002
791 DERMATITIS ALLERGIC 2 0.0002
792 HYPOCALCAEMIA 3 0.0002
793 BRAIN OEDEMA 2 0.0002
794 GASTRIC ULCER 3 0.0002
795 PROTEINURIA 3 0.0002
796 FEELING JITTERY 3 0.0002
797 INCREASED APPETITE 3 0.0002
798 ACUTE KIDNEY INJURY 24 0.0002
799 INJECTION SITE SWELLING 12 0.0002
800 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
801 SEROTONIN SYNDROME 3 0.0002
802 ERECTILE DYSFUNCTION 4 0.0002
803 ANAPHYLACTIC SHOCK 4 0.0002
804 EXPOSURE VIA SKIN CONTACT 4 0.0002
805 INCORRECT DOSE ADMINISTERED 35 0.0002
806 PRODUCT DOSE OMISSION 10 0.0002
807 MOBILITY DECREASED 11 0.0002
808 SEDATION 4 0.0002
809 APPLICATION SITE ERYTHEMA 4 0.0002
810 BEDRIDDEN 2 0.0002
811 DISABILITY 3 0.0002
812 DISORIENTATION 6 0.0002
813 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
814 SKIN DISORDER 5 0.0001
815 SPINAL FRACTURE 3 0.0001
816 URTICARIA 25 0.0001
817 FREQUENT BOWEL MOVEMENTS 4 0.0001
818 ANGER 5 0.0001
819 ALOPECIA 29 0.0001
820 RASH PRURITIC 8 0.0001
821 DISEASE RECURRENCE 7 0.0001
822 MYALGIA 25 0.0001
823 PALLOR 4 0.0001
824 CORONARY ARTERY OCCLUSION 2 0.0001
825 BLOOD GLUCOSE DECREASED 7 0.0001
826 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
827 APPLICATION SITE RASH 2 0.0001
828 RESPIRATORY DISTRESS 4 0.0001
829 NIGHTMARE 5 0.0001
830 HOSPITALISATION 22 0.0001
831 SKIN EXFOLIATION 12 0.0001
832 DECREASED APPETITE 33 0.0001
833 SUICIDAL IDEATION 13 0.0001
834 BLINDNESS UNILATERAL 2 0.0001
835 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
836 LOSS OF CONSCIOUSNESS 18 0.0001
837 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
838 BRONCHOSPASM 2 0.0001
839 HYPERSENSITIVITY 26 0.0001
840 CARDIOGENIC SHOCK 2 0.0001
841 HYPOACUSIS 6 0.0001
842 LETHARGY 8 0.0001
843 CARDIAC DISORDER 13 0.0001
844 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
845 FAECES DISCOLOURED 3 0.0001
846 NO ADVERSE EVENT 25 0.0001
847 INJECTION SITE HAEMORRHAGE 11 0.0001
848 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
849 PRODUCT PRESCRIBING ISSUE 3 0.0001
850 DRUG EFFECT INCOMPLETE 5 0.0001
851 APATHY 2 0.0001
852 DYSSTASIA 4 0.0001
853 THROMBOSIS 11 0.0001
854 RESTLESSNESS 5 0.0001
855 AGITATION 10 0.0001
856 PSYCHOTIC DISORDER 4 0.0001
857 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
858 URINARY INCONTINENCE 4 0.0001
859 OESOPHAGEAL CARCINOMA 4 0.0001
860 RENAL INJURY 4 0.0001
861 COLON CANCER 2 0.0001
862 NERVOUSNESS 7 0.0001
863 DEVICE ISSUE 12 0.0001
864 CHROMATURIA 3 0.0001
865 BRADYCARDIA 7 0.0001
866 COLITIS 5 0.0001
867 DRUG DISPENSING ERROR 2 0.0001
868 DEVICE ADHESION ISSUE 2 0.0001
869 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
870 FEMUR FRACTURE 4 0.0001
871 EJECTION FRACTION DECREASED 2 0.0001
872 COGNITIVE DISORDER 6 0.0001
873 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
874 DEVICE MALFUNCTION 9 0.0001
875 OFF LABEL USE 111 0.0001
876 DRUG INTERACTION 20 0.0001
877 RASH ERYTHEMATOUS 6 0.0001
878 MOOD SWINGS 4 0.0001
879 ABSCESS 2 0.0001
880 BLOOD PRESSURE FLUCTUATION 3 0.0001
881 BLISTER 7 0.0001
882 MOVEMENT DISORDER 4 0.0001
883 EXTRA DOSE ADMINISTERED 5 0.0001
884 DEVICE BREAKAGE 5 0.0001
885 CEREBRAL INFARCTION 3 0.0001
886 CONVULSION 7 0.0001
887 CHOLELITHIASIS 4 0.0001
888 LUNG NEOPLASM MALIGNANT 5 0.0001
889 PRODUCT USE IN UNAPPROVED INDICATION 30 0.0001
890 VISUAL ACUITY REDUCED 4 0.0001
891 AGEUSIA 3 0.0001
892 ADVERSE EVENT 11 0.0001
893 BREAST CANCER 11 0.0001
894 HAEMOGLOBIN DECREASED 12 0.0001
895 RECTAL HAEMORRHAGE 5 0.0001
896 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
897 ILL-DEFINED DISORDER 7 0.0001
898 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
899 RASH MACULAR 4 0.0001
900 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
901 DERMATITIS ATOPIC 6 0.0001
902 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
903 MENSTRUATION IRREGULAR 3 0.0001
904 FEAR 3 0.0001
905 CONFUSIONAL STATE 18 0.0001
906 DISTURBANCE IN ATTENTION 6 0.0001
907 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
908 THROAT TIGHTNESS 3 0.0001
909 PANIC ATTACK 4 0.0001
910 TREATMENT NONCOMPLIANCE 6 0.0001
911 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
912 TREATMENT FAILURE 9 0.0001
913 BLOOD GLUCOSE ABNORMAL 2 0.0001
914 INJECTION SITE MASS 4 0.0001
915 HAEMOPTYSIS 3 0.0001
916 RENAL DISORDER 5 0.0001
917 CEREBROVASCULAR ACCIDENT 18 0.0001
918 ACNE 8 0.0001
919 DIABETES MELLITUS 8 0.0001
920 PANCREATIC CARCINOMA 3 0.0001
921 DYSTONIA 2 0.0001
922 PRODUCT STORAGE ERROR 9 0.0001
923 LABORATORY TEST ABNORMAL 3 0.0001
924 ABNORMAL BEHAVIOUR 4 0.0001
925 ADVERSE DRUG REACTION 9 0.0001
926 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
927 EPILEPSY 3 0.0001
928 BODY TEMPERATURE INCREASED 2 0.0001
929 SKIN BURNING SENSATION 7 0.0001
930 EMOTIONAL DISORDER 3 0.0001
931 UNDERDOSE 7 0.0001
932 DRUG-INDUCED LIVER INJURY 3 0.0001
933 BLOOD GLUCOSE INCREASED 18 0.0001
934 PULMONARY EMBOLISM 9 0.0001
935 PANCREATITIS 5 0.0001
936 DEPRESSED MOOD 5 0.0001
937 RENAL FAILURE ACUTE 4 0.0001
938 METABOLIC ACIDOSIS 3 0.0001
939 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
940 HAEMATOCHEZIA 5 0.0001
941 PRODUCT QUALITY ISSUE 12 0.0001
942 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
943 CARDIAC FAILURE 7 0.0001
944 DEVICE USE ERROR 3 0.0001
945 HYPERKALAEMIA 3 0.0001
946 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
947 CEREBRAL HAEMORRHAGE 3 0.0001
948 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
949 MULTIPLE SCLEROSIS 4 0.0001
950 OVERDOSE 18 0.0001
951 C-REACTIVE PROTEIN INCREASED 3 0.0001
952 ENCEPHALOPATHY 2 0.0001
953 ABDOMINAL PAIN LOWER 2 0.0001
954 CARDIOVASCULAR DISORDER 2 0.0001
955 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
956 DEEP VEIN THROMBOSIS 5 0.0001
957 ECZEMA 4 0.0001
958 ANHEDONIA 2 0.0001
959 DISEASE PROGRESSION 9 0.0001
960 DEVICE DIFFICULT TO USE 5 0.0001
961 NEOPLASM MALIGNANT 5 0.0001
962 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
963 MEDICATION ERROR 4 0.0001
964 SEIZURE 8 0.0001
965 DEVICE LEAKAGE 3 0.0001
966 DEVICE DISLOCATION 3 0.0001
967 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
968 IRRITABILITY 4 0.0001
969 EMOTIONAL DISTRESS 8 0.0001
970 CORONARY ARTERY DISEASE 2 0.0001
971 DRUG ADMINISTRATION ERROR 2 0.0001
972 MYOCARDIAL INFARCTION 11 0.0001
973 RENAL IMPAIRMENT 5 0.0001
974 DELIRIUM 2 0.0001
975 HAEMORRHAGE 6 0.0001
976 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
977 HYPONATRAEMIA 3 0.0001
978 DEATH 43 0.0000
979 VERTIGO 3 0.0000
980 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
981 CARDIAC ARREST 4 0.0000
982 ANGIOEDEMA 2 0.0000
983 THROMBOCYTOPENIA 5 0.0000
984 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
985 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
986 COMA 2 0.0000
987 DRUG INTOLERANCE 3 0.0000
988 TOXICITY TO VARIOUS AGENTS 5 0.0000
989 DRUG DEPENDENCE 4 0.0000